Actively Recruiting

Phase Not Applicable
Age: 18Years - 100Years
All Genders
ID05353946

CRATER Trial: Coronary Rotational Atherectomy Elective vs. Bailout in Patients With Severely Calcified Lesions and Chronic Renal Failure

Led by Guillermo Galeote; MD, PhD · Updated on 2022-04-29

124

Participants Needed

1

Research Sites

48 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying the use of rotational atherectomy in patients with severely calcified coronary artery lesions, especially those with chronic kidney disease, which is linked to more severe arterial calcification. The study aims to compare the healthcare costs and outcomes between elective rotational atherectomy and conventional angioplasty (bailout) in this patient group, as there is currently no direct randomized comparison using intravascular ultrasound to assess calcification severity. Participants will be randomly assigned to either receive elective rotational atherectomy or start with conventional angioplasty, with rotational atherectomy used only if needed as a bailout. The procedure uses a Rotablator system that rotates a diamond-coated burr to remove calcified plaque, followed by intravascular ultrasound-guided stent placement. The study evaluates costs, success of stent expansion, procedure time, radiation exposure, complications, and cardiovascular events over medium-term follow-up. During the study, participants will undergo detailed imaging with intravascular ultrasound, angioplasty, and stent placement procedures. Researchers will monitor healthcare costs up to 30 days and over 5 years, procedure and fluoroscopy times, contrast-induced kidney injury, periprocedural and in-hospital complications, and major cardiovascular events up to 5 years after the procedure. The total participation duration includes these follow-up periods to assess safety and outcomes.

CONDITIONS

Brief Title

Coronary Rotational Atherectomy Elective vs. Bailout in Severely Calcified Lesions and Chronic Renal Failure

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients over 18 years old
  • Chronic kidney disease with glomerular filtration rate below 60 mL/min/1.73 m2 for 3 months or more
  • Coronary artery stenosis of 70% or greater in vessels 2.5 mm or larger
  • Severe calcification visible on both sides of the coronary artery lumen
  • Any clinical situation except acute myocardial infarction within the first 7 days
  • Native coronary vessels or bypass grafts eligible
Not Eligible

You will not qualify if you...

  • No informed consent provided
  • Acute myocardial infarction within the first 7 days
  • Lesion in only one patent vessel
  • Calcified lesions with angulation greater than 60 degrees, dissections, thrombus, or degenerated vein grafts
  • Hemodynamically unstable patients
  • Allergy to iodinated contrast media
  • Significant other illnesses with life expectancy under one year

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Periprocedural period including hospitalization until discharge

Participants receive a coronary procedure using either elective rotational atherectomy or conventional angioplasty with possible bailout atherectomy, guided by intravascular ultrasound to treat severely calcified coronary lesions.

1 procedure visit and hospitalization stay

Follow-up

Duration - Up to 5 years after the procedure

Participants are monitored for major cardiovascular events and healthcare outcomes up to 5 years after the procedure.

Visits at 1, 2, 3, 4, and 5 years after procedure

Trial Site Locations

Total: 1 location

1

La Paz University Hospital

Madrid, Spain, 28046

Actively Recruiting

Loading map...

Research Team

G

Guillermo Galeote, PhD, MD

A

Artemio García-Escobar, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Elut...

Elevated Lipoprotein(a) Level

Actively Recruiting

1 location

A 10-Minute Cardiovascular Magnetic Resonance Protocol for C...

Coronary Artery Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here